- 2024-08-20 02:12抑制剂SGN-2FF|SGN-2FF|2089647-47-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂Shield-1|Shield-1|914805-33-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:12抑制剂SGC-AAK1-1|SGC-AAK1-1|2247894-32-0|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:12抑制剂SGC-AAK1-1|SGC-AAK1-1|2247894-32-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂SGC-CBP30|SGC-CBP30|1613695-14-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:12抑制剂SGN-2FF|SGN-2FF|2089647-47-0|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:12抑制剂SEW2871|SEW2871|256414-75-2|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:12抑制剂SEW2871|SEW2871|256414-75-2|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:12抑制剂SEW2871|SEW2871|256414-75-2|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂SGC-AAK1-1|SGC-AAK1-1|2247894-32-0|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:12抑制剂SERCA2a activator 1|SERCA2a activator 1|2139330-34-8|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:12抑制剂SERCA2a activator 1|SERCA2a activator 1|2139330-34-8|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:12抑制剂SERCA2a activator 1|SERCA2a activator 1|2139330-34-8|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂Serdemetan|Serdemetan|881202-45-5|Adamas life|≥98%（以实测数值为准）|BR|100mg
- 2024-08-20 02:12抑制剂Sepimostat |Sepimostat |103926-64-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 02:12抑制剂Sepimostat |Sepimostat |103926-64-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 02:12抑制剂Sepimostat |Sepimostat |103926-64-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂SEP-363856 hydrochloride|SEP-363856 hydrochloride|1310422-41-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 02:12抑制剂Sepimostat dimethanesulfonate |Sepimostat dimethanesulfonate |103926-82-5|Adamas life|≥98%（以实测数值为
- 2024-08-20 02:12抑制剂Sepimostat dimethanesulfonate |Sepimostat dimethanesulfonate |103926-82-5|Adamas life|≥98%（以实测数值为
